ArticleJournal of gastrointestinal oncology2025

CYSTM1 is a potential diagnostic and prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.

Ning Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.